Draft dQM CMS Content Implementation Guide, published by cqframework. This guide is not an authorized publication; it is the continuous build for version 2025.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cqframework/dqm-content-cms-2025/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON

Measure: Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)FHIR

Official URL: https://madie.cms.gov/Measure/CMS135FHIRACEIorARBorARNIforHF				Version: 1.0.000
Active as of 2026-01-16			Responsible: American Heart Association	Computable Name: CMS135FHIRACEIorARBorARNIforHF
Other Identifiers: Short Name: CMS135FHIR (use: usual, ), UUID:86136d6c-dbe1-4b7f-89f3-406cb90f08d5 (use: official, ), UUID:a0aa7f51-9882-4ceb-b4e5-bb94669b62ca (use: official, ), Endorser: 0081e (use: official, ), Publisher: 135FHIR (use: official, )
Copyright/Legal: Copyright 2025 American College of Cardiology and American Heart Association. All Rights Reserved.

Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) <=40% who were prescribed or already taking ACE inhibitor or ARB or ARNI therapy during the measurement period